Advent Life Sciences will manage an impact investment vehicle for Harrington Discovery Institute.

US-based hospital and accelerator operator Harrington Discovery Institute (HDI) has set up an impact investment fund to be managed by venture capital firm Advent Life Sciences. The impact fund is structured alongside Advent Life Sciences’ third fund and brings a total of $215m of commitments to the firm. Advent-Harrington Impact Fund is set up as…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.